Famotidine
- Product NDC
- 60219-2090
- 11-digit product format
- 602192090
- Labeler code
- 60219
- Product ID
- 60219-2090_ec5e06f5-b43c-4f18-848f-590cb7948210
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Famotidine
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA216427
- Marketing category
- ANDA
- Marketing start
- 2024-05-13
- Substance
- FAMOTIDINE
- Active strength
- 40 mg/5mL
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Famotidine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FAMOTIDINE | 40 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5QZO15J2Z8 |
| Rxcui | 310274 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60219-2090-4 | Famotidine | 50 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 50 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60219-2090 | FAMOTIDINE POWDER, FOR SUSPENSION [AMNEAL PHARMACEUTICALS NY LLC] | 1 | Current NDC, 1 package rows | 20240514_443e8ea6-7d51-4db7-8f0b-7a854d45bf23.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 60219-2090-4 | 60219209004 | 50 mL in 1 BOTTLE (60219-2090-4) | 50 ml | 2024-05-13 | No | No | Current |